Loading the company…
Loading the company…
In the last ten years FDA made 5 decisions for Peca Labs (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (1). The latest was on 2024-01-17.
| Family | Decisions on record |
|---|---|
| Dialysis access | 5 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-01-17 | 510(k) | K233783 | exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular Grafts |
| 2022-08-04 | 510(k) | K221628 | exGraft, exGraft Carbon |
| 2020-12-11 | 510(k) | K202471 | exGraft ePTFE Vascular Graft, exGraft Carbon ePTFE Vascular Graft |
| 2019-04-22 | 510(k) | K183613 | exGraft, exGraft Carbon |
| 2018-08-21 | 510(k) |
| K180957 |
| exGraft, exGraft Carbon ePTFE Vascular Grafts |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Peca Labs.